Browsing Tag
Jordan
9 posts
Hikma delivers strong H1 performance and upgrades Group guidance
Hikma Pharmaceuticals PLC and its subsidiaries (‘Hikma’ or ‘Group’), the multinational pharmaceutical company, today reports its interim results…
Hikma expands its agreement with AFT Pharmaceuticals for the commercialisation of injectable pain medication Combogesic® into the Saudi, Jordanian and Iraqi Markets
Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, has announced that it has recently signed an exclusive licencing agreement…
Unveiling the Strategic Partnership between IBS and Centrika Limited for the African Market Launch
Following multiple successes in GCC, mainly KSA, Qatar, and Kuwait; Infinite Business Solutions – IBS (Dubai-HQ Jordanian-Emirati company)…
Hikma and SK Biopharmaceuticals enter a strategic partnership for the Middle East and North Africa
Amman, Jordan — Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces a new strategic partnership and exclusive…
Talmix and Khibraty Join Forces to Revolutionize On-Demand Business Talent in the MENA Region
LONDON, England & AMMAN, Jordan — Talmix, the global business talent marketplace, and Khibraty, the leading MENA digital…
Riad Mishlawi named Chief Executive Officer of Hikma Pharmaceuticals PLC
Amman,Jordan — Hikma Pharmaceuticals PLC (Hikma, Group), announces that Riad Mishlawi, President of the Group’s Injectables business, has…
Hikma delivers a resilient underlying performance in 2022
Amman, Jordan — Hikma Pharmaceuticals PLC (‘Hikma’ or ‘Group’), the multinational pharmaceutical company, today reports its preliminary audited…
Award-Winning Startappz Launches ‘The Bank’ Case Study
AMMAN, Jordan — Startappz, the award-winning company, is a digital experience provider that partners with leading telecom operators,…
Hikma and Adalvo Sign Exclusive Licensing Agreement to Commercialise Allergic Rhinitis Medication across MENA Markets
Amman, Jordan — Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces an exclusive licensing agreement with Adalvo…